Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
Sean J. Pittock(Mayo Clinic), Sebastian A. Lopez Chiriboga(Mayo Clinic), Katie Dunlay(Mayo Clinic), Melanie Ramberger(German Center for Neurodegenerative Diseases), Αναστασία Ζεκερίδου(Mayo Clinic), Patrick Waters(University of Oxford), Jessica Sagen(Mayo Clinic), Sarosh R. Irani(Jacksonville College), Michelle F. Devine(Mayo Clinic), Andrew McKeon(Mayo Clinic), Jeffrey W. Britton(Mayo Clinic in Arizona), Jane H. Cerhan(Mayo Clinic), Avi Gadoth(Tel Aviv University)
Cited by 159
Related Papers
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
Revised diagnostic criteria for neuromyelitis optica
|Neurology|2006|2.6k
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
|The Journal of Experimental Medicine|2005|2.3k